Clinical Trials
2 trialsNCT06319313 2024-03-20
Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 2/3 Not yet recruiting
NCT01642004 2022-12-28
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Bristol-Myers Squibb
Phase 3 Completed